Interest of an Auriculotherapy Session in Smoking Cessation (NCT04880330) | Clinical Trial Compass
CompletedNot Applicable
Interest of an Auriculotherapy Session in Smoking Cessation
France90 participantsStarted 2021-11-16
Plain-language summary
The aim of the study is to show that auriculotherapy is effective in smoking cessation.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Be of legal age
* Have an active smoking habit
* Wish to quit smoking and nicotine completely (VAS of motivation ≥ 7 on a scale of 0 to 10)
* Have signed a consent form;
* Be affiliated with a health insurance plan.
Exclusion Criteria:
* Contraindication to the use of auriculotherapy (lesion or infection of the auricle) by cryotherapy (skin healing disorder, risk of hypo or hyperpigmentation);
* Treatment with Varenicline (Champix®, etc...) or Bupropion hydrochloride (Zyban®, etc...) in progress; treatment with nicotine substitutes (patches, gum, nicotine e-cigarette)
* Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months;
* Previous treatment with cryo-auriculotherapy;
* Having to start any new smoking cessation treatment that could interfere with the study: specific drug treatment (antidepressant, morphine, anticonvulsant) or complementary therapy (psychological or mind-body treatment);
* Difficulty complying with the treatment, questionnaire or study protocol;
* Being deprived of liberty or under guardianship.
What they're measuring
1
Confirmation that cryotherapy auriculotherapy is effective in the treatment of smoking cessation compared to a "sham" treatment (without N2O).